Torrent Pharmaceuticals Ltd.

•

torrentpharma.comBSE: 500420NSE: TORNTPHARM

Market Cap₹ 1,87,594 Cr.

Current Price

High / Low₹ 5,250 / 3,481

Stock P/E87.9

Book Value₹ 236

Price to Book16.90

Dividend Yield0.77 %

ROCE19.8 %

ROE27.3 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 24.6%
Company has a healthy return on capital (ROCE) of 22.8%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.51x)
Operating margins have improved to 35.8% from 32.5%
Company has been maintaining a healthy dividend payout of 58.7%

CONS

Company has a high debt-to-equity of 1.68x
Promoter holding has decreased over last 2 years: -2.9pp
Total debt has risen sharply - up 456.1% year on year
Stock is trading at 16.9x its book value
Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY NEXT 50 NIFTY PHARMA NIFTY500MOMENTM50 NIFTYLARGEMIDCAP250 NIFTY100 LOWVOL30

S.No.	Name
1.	SUNPHARMA	1868.50	37.06	448315.74	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9482.75	86.06	251737.22	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4931.90	86.01	187593.62	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1129.00	24.95	112618.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1368.00	32.79	110515.04	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1933.25	95.54	104455.86	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1690.00	26.19	97238.86	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	LUPIN	2092.00	17.30	95660.02	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
9.	DRREDDY	1143.20	29.61	95420.61	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	MANKIND	2266.00	45.82	93596.02	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2439.55	38.29	68850.12	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BIOCON	395.00	129.97	64372.92	0.13	136.80	53.36	4336.00	10.89	3.26	19.54

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2,078	2,115	2,083	2,094	2,394	2,376	2,330	2,385	2,567	2,707	2,547	2,677	4,158
	1,384	1,410	1,422	1,427	1,539	1,513	1,490	1,565	1,637	1,690	1,599	1,732	3,453
Operating Profit	694	705	661	667	855	863	840	820	930	1,017	948	945	705
OPM %	33.40%	33.33%	31.73%	31.85%	35.71%	36.32%	36.05%	34.38%	36.23%	37.57%	37.22%	35.30%	16.96%
	11	15	-11	76	21	-7	3	-9	-5	-40	-18	11	0
Interest	90	77	69	67	64	54	48	47	45	37	34	225	293
Depreciation	183	192	191	195	189	190	191	190	187	189	191	197	575
Profit before Tax	475	482	430	530	667	670	651	622	742	806	757	592	663
Tax %	32.00%	32.16%	30.93%	22.64%	29.69%	31.34%	25.50%	23.79%	25.74%	25.93%	23.78%	21.11%	25.79%
Net Profit	323	327	297	410	469	460	485	474	551	597	577	467	492
	9.55	9.65	8.78	12.12	13.86	13.60	14.33	14.00	16.28	17.64	17.04	13.80	12.94

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	4,551	4,244	5,762	6,168	6,451	6,742	7,695	8,533	9,682	10,712	12,089
	3,424	3,337	4,149	4,251	4,259	4,642	5,230	5,644	6,107	6,795	8,474
Operating Profit	1,127	907	1,613	1,917	2,192	2,101	2,465	2,889	3,576	3,917	3,615
OPM %	24.76%	21.38%	27.99%	31.08%	33.98%	31.16%	32.04%	33.86%	36.93%	36.56%	29.90%
	300	332	382	237	118	204	82	91	7	84	-47
Interest	202	294	481	430	334	236	298	303	213	341	589
Depreciation	269	384	579	607	610	602	672	761	759	764	1,152
Profit before Tax	955	562	935	1,117	1,366	1,466	1,577	1,917	2,610	2,897	2,818
Tax %	10.55%	14.25%	20.29%	15.96%	16.71%	32.38%	33.33%	29.19%	27.67%	24.34%	24.31%
Net Profit	854	482	745	939	1,138	991	1,051	1,357	1,888	2,192	2,133
EPS	50.48	28.48	44.05	55.46	67.24	29.29	31.07	40.10	55.78	64.75	—
Dividend Payout %	27.74%	49.15%	38.60%	57.71%	52.06%	81.94%	70.82%	69.83%	57.36%	58.69%	—

COMPOUNDED SALES GROWTH

10 Years:: 7%
5 Years:: 11%
3 Years:: 12%

COMPOUNDED PROFIT GROWTH

10 Years:: 2%
5 Years:: 14%
3 Years:: 28%

STOCK PRICE CAGR

10 Years:: 20%
5 Years:: 26%
3 Years:: 38%
1 Year:: 37%

RETURN ON EQUITY

10 Years:: 19%
5 Years:: 21%
3 Years:: 25%
Last Year:: 27%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	85	85	85	85	85	85	169	169	169	169
	4,369	4,472	4,931	5,036	5,945	6,261	6,287	6,660	7,423	8,283
	2,467	5,874	5,647	5,398	4,448	3,390	4,641	2,982	2,335	14,210
Trade Payables	548	776	582	682	648	624	611	760	767	806
	582	613	782	616	607	793	1,164	1,807	2,147	2,345
Total Liabilities	8,051	11,819	12,027	11,817	11,733	11,153	12,872	12,377	12,842	25,814
	3,523	7,429	7,425	7,198	6,741	6,251	7,972	7,986	7,554	7,357
Capital Work in Progress	462	423	471	513	555	544	675	204	366	384
	936	625	486	135	314	368	361	463	523	13,172
	1,032	1,299	1,358	1,508	1,912	1,797	1,602	1,566	1,561	1,526
	0	0	0	0	0	0	0	1,572	2,171	2,641
Cash & Bank	78	57	238	391	66	69	148	109	110	83
	2,019	1,986	2,049	2,072	2,145	2,124	2,114	477	558	650
Total Assets	8,051	11,819	12,027	11,817	11,733	11,153	12,872	12,377	12,842	25,814

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	935	1,061	1,440	1,787	1,783	2,380	2,538	2,893	2,574	2,731
Cash from Investing	-533	-4,207	-373	269	-316	-160	-2,384	-296	-470	-12,990
Cash from Financing	-131	2,929	-928	-1,555	-1,581	-1,977	81	-2,578	-2,104	10,225
	16	-349	-69	294	-325	3	-38	19	-0	-34

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.25	71.25	68.31	68.31	68.31	68.31	68.31	68.31	68.31
	14.22	14.46	16.17	16.31	16.09	15.92	16.13	16.18	15.44
	7.17	6.98	8.25	8.25	8.54	9.17	9.05	8.96	9.73
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	7.26	7.21	7.17	7.03	6.94	6.49	6.42	6.45	6.42

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - Torrent Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-09-09

Copy of Newspaper Publication

2026-09-09 - Torrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Newspaper advertisement in respect of special window for transfer and dematerialization requests of physical shares

2026-09-07

Shareholders meeting

2026-09-07 - Torrent Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

2026-08-11

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-11 - Torrent Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-08-11

General Updates

2026-08-11 - Torrent Pharmaceuticals Limited has informed the Exchange about General Updates

2026-08-06

Copy of Newspaper Publication

2026-08-06 - Torrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - Postal Ballot notice

2026-08-05

Shareholders meeting

2026-08-05 - Torrent Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot

2026-08-04

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-04 - Torrent Pharmaceuticals Limited has informed the Exchange about Transcript

2026-08-01

Change in Director(s)

2026-08-01 - Torrent Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.

News

Recent coverage and analyst commentary for TORNTPHARM

Loading news…

🤖

AI Stock Analyst

Torrent Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1868.50

37.06

448315.74

0.86

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9482.75

86.06

251737.22

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4931.90

86.01

187593.62

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1129.00

24.95

112618.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1368.00

32.79

110515.04

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1933.25

95.54

104455.86

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

AUROPHARMA

1690.00

26.19

97238.86

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2092.00

17.30

95660.02

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1143.20

29.61

95420.61

0.70

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2266.00

45.82

93596.02

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2439.55

38.29

68850.12

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

BIOCON

395.00

129.97

64372.92

0.13

136.80

53.36

4336.00

10.89

3.26

19.54

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

2,078

2,115

2,083

2,094

2,394

2,376

2,330

2,385

2,567

2,707

2,547

2,677

4,158

1,384

1,410

1,422

1,427

1,539

1,513

1,490

1,565

1,637

1,690

1,599

1,732

3,453

Operating Profit

694

705

661

667

855

863

840

820

930

1,017

948

945

705

OPM %

33.40%

33.33%

31.73%

31.85%

35.71%

36.32%

36.05%

34.38%

36.23%

37.57%

37.22%

35.30%

16.96%

-11

-7

-9

-5

-40

-18

Interest

225

293

Depreciation

183

192

191

195

189

190

191

190

187

189

191

197

575

Profit before Tax

475

482

430

530

667

670

651

622

742

806

757

592

663

Tax %

32.00%

32.16%

30.93%

22.64%

29.69%

31.34%

25.50%

23.79%

25.74%

25.93%

23.78%

21.11%

25.79%

Net Profit

323

327

297

410

469

460

485

474

551

597

577

467

492

9.55

9.65

8.78

12.12

13.86

13.60

14.33

14.00

16.28

17.64

17.04

13.80

12.94

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

4,551

4,244

5,762

6,168

6,451

6,742

7,695

8,533

9,682

10,712

12,089

3,424

3,337

4,149

4,251

4,259

4,642

5,230

5,644

6,107

6,795

8,474

Operating Profit

1,127

907

1,613

1,917

2,192

2,101

2,465

2,889

3,576

3,917

3,615

OPM %

24.76%

21.38%

27.99%

31.08%

33.98%

31.16%

32.04%

33.86%

36.93%

36.56%

29.90%

300

332

382

237

118

204

-47

Interest

202

294

481

430

334

236

298

303

213

341

589

Depreciation

269

384

579

607

610

602

672

761

759

764

1,152

Profit before Tax

955

562

935

1,117

1,366

1,466

1,577

1,917

2,610

2,897

2,818

Tax %

10.55%

14.25%

20.29%

15.96%

16.71%

32.38%

33.33%

29.19%

27.67%

24.34%

24.31%

Net Profit

854

482

745

939

1,138

991

1,051

1,357

1,888

2,192

2,133

EPS

50.48

28.48

44.05

55.46

67.24

29.29

31.07

40.10

55.78

64.75

—

Dividend Payout %

27.74%

49.15%

38.60%

57.71%

52.06%

81.94%

70.82%

69.83%

57.36%

58.69%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

169

4,369

4,472

4,931

5,036

5,945

6,261

6,287

6,660

7,423

8,283

2,467

5,874

5,647

5,398

4,448

3,390

4,641

2,982

2,335

14,210

Trade Payables

548

776

582

682

648

624

611

760

767

806

582

613

782

616

607

793

1,164

1,807

2,147

2,345

Total Liabilities

8,051

11,819

12,027

11,817

11,733

11,153

12,872

12,377

12,842

25,814

3,523

7,429

7,425

7,198

6,741

6,251

7,972

7,986

7,554

7,357

Capital Work in Progress

462

423

471

513

555

544

675

204

366

384

936

625

486

135

314

368

361

463

523

13,172

1,032

1,299

1,358

1,508

1,912

1,797

1,602

1,566

1,561

1,526

1,572

2,171

2,641

Cash & Bank

238

391

148

109

110

2,019

1,986

2,049

2,072

2,145

2,124

2,114

477

558

650

Total Assets

8,051

11,819

12,027

11,817

11,733

11,153

12,872

12,377

12,842

25,814

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

935

1,061

1,440

1,787

1,783

2,380

2,538

2,893

2,574

2,731

Cash from Investing

-533

-4,207

-373

269

-316

-160

-2,384

-296

-470

-12,990

Cash from Financing

-131

2,929

-928

-1,555

-1,581

-1,977

-2,578

-2,104

10,225

-349

-69

294

-325

-38

-0

-34

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

71.25

68.31

14.22

14.46

16.17

16.31

16.09

15.92

16.13

16.18

15.44

7.17

6.98

8.25

8.54

9.17

9.05

8.96

9.73

Government

0.00

7.26

7.21

7.17

7.03

6.94

6.49

6.42

6.45

6.42

Torrent Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Torrent Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI